pyridostigmine 是一种乙酰胆碱酯酶抑制剂，可通过增加突触后运动终板的乙酰胆碱来治疗重症肌无力。
产品描述
Pyridostigmine is an acetylcholinesterase inhibitor that can treat myasthenia gravis by increasing acetylcholine at the postsynaptic motor endplate.
体内活性
Pyridostigmine holds promise for the treatment of various gastrointestinal symptoms in SSc patients, particularly in patients with refractory constipation. Though side effects may limit its use, most patients who experienced benefit chose to continue therapy[1].
Cas No.
155-97-5
分子式
C9H13BrN2O2
分子量
261.116
别名
Regonol;Pyridostigminum;PyridostigmineBromine;UNII-19QM69HH21;Mestinon-SR;pyridostigmine
储存和溶解度
DMSO:10 mM
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
